Fleischmann R, et al. A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate. ACR 2018, abstract 890.
IL-23: de schakel tussen arthritis psoriatica, psoriasis en Crohn?
jul 2017 | Arthritis psoriatica